Monday, October 3, 2022

Evening: FDA Preparing to Publish Study on 4 Potential Adverse Events Following Pfizer Vaccination

U.S. Food and Drug Administration (FDA) researchers are preparing to publish a study on a set of dat... ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
October 3, 2022
TODAY IN HISTORY
President Lincoln proclaims official Thanksgiving holiday
1863
TOP NEWS
FDA Preparing to Publish Study on 4 Potential Adverse Events Following Pfizer Vaccination
FDA Preparing to Publish Study on 4 Potential Adverse Events Following Pfizer Vaccination
Share*             READ MORE
The information you trust for the 2022 midterms

Learn about the political trends, demographic shifts, campaign strategies, and key themes impacting the 2022 election—so you can make the decision that's truest to your values.

Subscribe to the digital edition of The Epoch Times and get a copy of our Decision 2022 special report mailed to your home.
Order Now While Supplies Last!
STORY
EPOCH TV
LIFESTYLE
EPOCH FUN
Epoch Fun
See today's Spot the Difference

Play our popular Crossword and Word Wipe

Want to play something else? See all games

Copyright © 2022 The Epoch Times. All rights reserved.

Our mailing address is: The Epoch Times. 229 W. 28 St. Fl. 7 New York, NY 10001 | Contact Us

 

*When sharing an article, giftaccess@TheEpochTimes.com is added to the list of recipients. If your friend is not already a subscriber, we will send them a special link for free access to the article.

Our Good Evening newsletter is one of the best ways to receive the most up-to-date information. If you no longer wish to receive these emails, unsubscribe here.

mt

No comments:

Post a Comment